3
Crest
®
+ Oral-B
®
at dentalcare.com
the potential to impact both oral and systemic
health. Given the impact of diet and on overall
health and oral health, oral healthcare providers
should strive to understand the interaction
between nutritional intake and periodontal
health.
Systemic Inflammation and Periodontal
Disease
Periodontal diseases are both infectious and
inflammatory diseases of the supporting
structures around the teeth: the gingiva,
periodontal ligament, alveolar bone, and
cementum.
2,9,10
The two most common forms
of periodontal disease are gingivitis and
periodontitis.
1
Gingivitis is a non-specific
inflammatory reaction to the accumulation of
dysbiotic bacterial biofilm.
11
All individuals are
susceptible to developing gingivitis after oral
hygiene procedures are stopped. Gingivitis is
also a necessary precursor to periodontitis and,
ultimately, a loss of hard and soft tissues around
the teeth.
11
Removal of biofilm and local etiologic
factors results in the reversal of gingivitis
symptoms and resolution of local and systemic
levels of inflammatory markers is associated
with reestablishment of gingival health.
11-13
Periodontitis is initiated by dysbiotic biofilm
accumulation in a susceptible host and
this biofilm dysbiosis triggers an immune-
inflammatory response that then leads to the
destruction of hard and soft tissues supporting
the teeth.
14-15
Periodontal disease progression
is generally slow to moderate. Average
clinical progression of periodontal disease
is approximately 0.1mm of attachment loss
and 0.2 teeth lost annually.
15
In longitudinal
investigations, groups with the fastest
and slowest disease progression differed
considerably with regard to demographics and
underlying health conditions.
16
In an updated
classification system from the American
Academy of Periodontology (AAP) and European
Federation of Periodontology (EFP), individuals
with periodontitis are classified with a Stage and
Grade, which are meant to capture both the
current state of disease severity and distribution
and risk of future disease progression based
upon the history of diease progression and
patient-level risk factors.
15,17
Periodontitis Stages
I-IV are assigned based upon patients’ current
clinical presentation of periodontitis, including
attachment loss, alveolar bone levels, and
tooth loss, and the Stage may be modified by
case complexity and need for multidisciplinary
care.
15,17
In order to describe the risk of future
disease progression, Periodontitis Grades A-C
are determined based upon individualized
patient risk factors (i.e. smoking status and
glycemic control) and direct and/or indirect
evidence of disease progression, including the
calculation of alveolar bone loss/age.
15,17
The
prevalence of periodontitis has been estimated
to be over 42% of U.S. adults over 30 years of
age.
1
Of those individuals, 7.8% were found to
have severe periodontitis.
1
Severe periodontitis
was also most prevalent among US adults
65 years or older, Mexican Americans, non-
Hispanic blacks, and current heavy (>10
cigarettes daily) smokers.
1
Among US adults,
periodontitis prevalence is nearly 4-fold greater
than that of diabetes mellitus
18
and over 6-fold
greater than that of coronary artery disease,
19
making it extremely common within the
population. Periodontal disease progression
and destruction of both hard and soft tissues
occurs through host-mediated inflammatory
pathways,
20
which may vary based upon
genetic and environmental risk factors,
potentially including nutritional factors.
2,20-23
It should also be noted that a number of
systemic diseases that are influenced by diet
and nutritional intake, including diabetes
mellitus, cardiovascular disease, and obesity
have been associated with periodontal disease
development or progression.
24-26
The process of periodontal tissue destruction
is mediated by pro-inflammatory cytokines
and mediators such as interleukin-1ß (IL-1ß),
interleukin-6 (IL-6), tumor necrosis factor-α
(TNF-α), prostaglandin E2 (PGE2), receptor
activator of nuclear factor kappa B ligand
(RANKL), and matrix metalloproteinases
(MMPs).
2,9,10
These pro-inflammatory
mediators drive the activation of osteoclastic
functions and lead to alveolar bone loss. The
heterogeneity of the immune-inflammatory
response among individuals can influence
disease susceptibility and severity.
2
Additionally,
periodontal disease severity is correlated to
increased levels of pro-inflammatory mediators
systemically.
27-30
Because dietary intake can